Jentadueto (linagliptin/metformin) - Eli Lilly, Boehringer Ingelheim
Jentadueto diabetes pill launched in the UK (Diabetes.co.uk) - Oct 18, 2012 - "A new drug treatment for type 2 diabetes that combines metformin with the DPP-4 inhibitor linagliptin in a single tablet is now available in the UK" 
Launch Europe Diabetes
http://www.diabetes.co.uk/news/2012/Oct/jentadueto-diabetes-pill-launched-in-the-uk-96025887.html
 
Oct 18, 2012
 
A new drug treatment for type 2 diabetes that combines metformin with the DPP-4 inhibitor linagliptin in a single tablet is now available in the UK. ... Jentadueto was approved in Europe in July following data from Phase III clinical trials, which showed that a twice-daily dose of the oral medication (2.5mg linagliptin/1000mg metformin) caused a significant reduction in blood sugar levels, compared to use of metformin (1000mg twice-daily) or linagliptin (5mg once-daily).